| Tracking cancer evolution reveals constrained routes to metastases: TRACERx renal S Turajlic, H Xu, K Litchfield, A Rowan, T Chambers, JI Lopez, D Nicol, ... Cell 173 (3), 581-594. e12, 2018 | 711 | 2018 |
| Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients B Nguyen, C Fong, A Luthra, SA Smith, RG DiNatale, S Nandakumar, ... Cell 185 (3), 563-575. e11, 2022 | 281 | 2022 |
| Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy C Krishna, RG DiNatale, F Kuo, RM Srivastava, L Vuong, D Chowell, ... Cancer cell 39 (5), 662-677. e6, 2021 | 203 | 2021 |
| A pan-cancer analysis of PBAF complex mutations and their association with immunotherapy response AA Hakimi, K Attalla, RG DiNatale, I Ostrovnaya, J Flynn, KA Blum, Y Ged, ... Nature communications 11 (1), 4168, 2020 | 53 | 2020 |
| Comprehensive molecular characterization and response to therapy in fumarate hydratase–deficient renal cell carcinoma JP Gleeson, I Nikolovski, R Dinatale, M Zucker, A Knezevic, S Patil, Y Ged, ... Clinical Cancer Research 27 (10), 2910-2919, 2021 | 52 | 2021 |
| Metastatic chromophobe renal cell carcinoma: Presence or absence of sarcomatoid differentiation determines clinical course and treatment outcomes Y Ged, YB Chen, A Knezevic, J Casuscelli, A Redzematovic, RG DiNatale, ... Clinical genitourinary cancer 17 (3), e678-e688, 2019 | 52 | 2019 |
| DNA damage repair pathway alterations in metastatic clear cell renal cell carcinoma and implications on systemic therapy Y Ged, JL Chaim, RG DiNatale, A Knezevic, RR Kotecha, MI Carlo, ... Journal for immunotherapy of cancer 8 (1), 2020 | 42 | 2020 |
| Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging M Kashan, M Ghanaat, AM Hötker, C Duzgol, A Sanchez, RG DiNatale, ... The Journal of urology 200 (2), 275-282, 2018 | 40 | 2018 |
| Comprehensive genomic analysis of translocation renal cell carcinoma reveals copy-number variations as drivers of disease progression J Marcon, RG DiNatale, A Sanchez, RR Kotecha, S Gupta, F Kuo, ... Clinical Cancer Research 26 (14), 3629-3640, 2020 | 39 | 2020 |
| Comparative genomic profiling of matched primary and metastatic tumors in renal cell carcinoma MF Becerra, E Reznik, A Redzematovic, DM Tennenbaum, M Kashan, ... European urology focus 4 (6), 986-994, 2018 | 35 | 2018 |
| Germline SDHA mutations in children and adults with cancer MD Gault, D Mandelker, D DeLair, CR Stewart, Y Kemel, MR Sheehan, ... Molecular Case Studies 4 (4), a002584, 2018 | 35 | 2018 |
| The clinicopathologic and molecular landscape of clear cell papillary renal cell carcinoma: implications in diagnosis and management S Weng, RG DiNatale, A Silagy, R Mano, K Attalla, M Kashani, K Weiss, ... European urology 79 (4), 468-477, 2021 | 34 | 2021 |
| Putative drivers of aggressiveness in TCEB1-mutant renal cell carcinoma: an emerging entity with variable clinical course RG DiNatale, AN Gorelick, V Makarov, KA Blum, AW Silagy, B Freeman, ... European urology focus 7 (2), 381-389, 2021 | 33 | 2021 |
| The association between small primary tumor size and prognosis in metastatic renal cell carcinoma: insights from two independent cohorts of patients who underwent cytoreductive … RG DiNatale, W Xie, MF Becerra, AW Silagy, K Attalla, A Sanchez, ... European urology oncology 3 (1), 47-56, 2020 | 33 | 2020 |
| Molecular characterization of sarcomatoid clear cell renal cell carcinoma unveils new candidate oncogenic drivers GG Malouf, R Flippot, Y Dong, RG Dinatale, YB Chen, X Su, E Compérat, ... Scientific reports 10 (1), 701, 2020 | 26 | 2020 |
| Spatiotemporal evolution of the clear cell renal cell carcinoma microenvironment links intra-tumoral heterogeneity to immune escape M Golkaram, F Kuo, S Gupta, MI Carlo, ML Salmans, R Vijayaraghavan, ... Genome Medicine 14 (1), 143, 2022 | 21 | 2022 |
| Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome P Murugan, L Jia, RG Dinatale, M Assel, N Benfante, HA Al-Ahmadie, ... Modern Pathology 35 (6), 825-835, 2022 | 21 | 2022 |
| High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab CH Lee, RG DiNatale, D Chowell, C Krishna, V Makarov, C Valero, ... Molecular Cancer Research 19 (9), 1510-1521, 2021 | 21 | 2021 |
| Impact of intraoperative opioid and adjunct analgesic use on renal cell carcinoma recurrence: role for onco-anaesthesia AW Silagy, ML Hannum, R Mano, K Attalla, JR Scarpa, RG DiNatale, ... British journal of anaesthesia 125 (5), e402-e404, 2020 | 20 | 2020 |
| Evolving biological associations of upfront cytoreductive nephrectomy in metastatic renal cell carcinoma AW Silagy, RR Kotecha, S Weng, A Holmes, N Singla, R Mano, K Attalla, ... Cancer 127 (21), 3946-3956, 2021 | 17 | 2021 |
